Pendal Group LTD Dexcom Inc Transaction History

Pendal Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 21, 2021	SELL	$78.0 - $104.5 $40,326 - $54,026	-517 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $32,405 - $54,460	517 New	517 $210,000
Q2 2019 Aug 01, 2019	SELL	$27.84 - $38.92 $293,517 - $410,333	-10,543 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$28.07 - $38.18 $295,942 - $402,531	10,543 New	10,543 $0

1,083

352M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.